Skip to playerSkip to main content
  • 5 years ago
Moderna ($MRNA@US) has agreed to a deal that will supply Japan with 50 million vaccine doses. Cases of COVID-19 have surged in Japan ahead of the 2020 Tokyo Olympics. Moderna is publicly traded on NASDAQ, and shares were up 6.6% at press time.